Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifurtimox for Relapsed/Refractory Neuroblastoma or Medulloblastoma
NCT00601003Phase 2Completed
- Start
- Jan 2008
- Primary completion
- Apr 2020
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of nifurtimox in neuroblastoma, medulloblastoma. Started Jan 2008; status: completed.
02
Drugs
nifurtimox
03
Conditions
neuroblastomamedulloblastoma
Beyond the preview
Go deeper on NCT00601003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601003.